Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study
Seoul National University Hospital · Georgetown University · +27 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
45
total citations
- FWCI
- 68.06
- Percentile
- 100%
- References
- 25
Citations per year
Authors
20- DODo‐Youn OhCorresponding
Seoul National University Hospital
- ARAiwu Ruth He
Georgetown University, Georgetown University Medical Center
- SQShukui Qin
Nanjing General Hospital of Nanjing Military Command, Jiangsu Cancer Hospital
- LCLi‐Tzong Chen
National Cheng Kung University Hospital, National Kaohsiung University of Applied Sciences
- TOTakuji Okusaka
Topics & keywords
Topics
Keywords
- Durvalumab
- Biliary tract cancer
- Medicine
- Topaz
- Biliary tract
- Chemotherapy
- Cancer
- Oncology
No related works found for this paper.